Biotechnology stocks
1,443 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dimerix LimitedASX: DXB | $133.41M | AU$0.31 | +5.08% |
| Medivir AB (publ)OM: MVIR | $131.58M | Skr2.03 | -2.40% |
| Pharmosa Biopharm Inc.TPEX: 6875 | $130.63M | NT$32.20 | -2.57% |
| Black Diamond Therapeutics, Inc.NasdaqGS: BDTX | $130.42M | $2.27 | -0.22% |
| Cibus, Inc.NasdaqCM: CBUS | $129.93M | $1.69 | -0.59% |
| ProMIS Neurosciences, Inc.NasdaqCM: PMN | $129.67M | $13.80 | -4.56% |
| NKGen Biotech Korea Co., Ltd.KOSDAQ: A182400 | $128.86M | ₩— | — |
| ADC Therapeutics SANYSE: ADCT | $127.23M | $1.11 | +11.38% |
| Cloudbreak Pharma Inc.SEHK: 2592 | $126.46M | HK$1.18 | -3.69% |
| Anixa Biosciences, Inc.NasdaqCM: ANIX | $126.23M | $3.59 | -3.23% |
| Captor Therapeutics Spolka AkcyjnaWSE: CTX | $125.60M | zł71.10 | -2.60% |
| Faron Pharmaceuticals OyAIM: FARN | $125.37M | £0.41 | +3.54% |
| Bio Solution Co.,Ltd.KOSDAQ: A086820 | $125.31M | ₩6,730.00 | +0.90% |
| Vaxart, Inc.OTCPK: VXRT | $125.06M | $0.52 | -5.24% |
| Bioventix PLCAIM: BVXP | $124.27M | £17.30 | -1.14% |
| Obigen Pharma Inc.TPEX: 7876 | $124.16M | NT$36.90 | +1.23% |
| Quantum Cyber N.V.NasdaqCM: QUCY | $124.00M | $1.49 | +0.68% |
| Biomea Fusion, Inc.NasdaqGS: BMEA | $123.95M | $1.71 | 0.00% |
| Sunho Biologics, Inc.SEHK: 2898 | $123.78M | HK$— | — |
| Genelux CorporationNasdaqCM: GNLX | $121.89M | $2.85 | +4.78% |
| Actinogen Medical LimitedASX: ACW | $120.61M | AU$0.05 | +1.10% |
| StemCyte International, Ltd.TWSE: 4178 | $120.09M | NT$17.80 | +0.56% |
| Bioceltix S.A.WSE: BCX | $119.85M | zł80.00 | 0.00% |
| Curasight A/SNGM: CURAS | $119.85M | Dkr16.00 | +12.68% |
| BNC KOREA, Inc.KOSDAQ: A256840 | $117.95M | ₩2,390.00 | -11.15% |
| SynAct Pharma ABOM: SYNACT | $117.32M | Skr19.44 | -2.02% |
| Hamlet BioPharma AB (publ)XSAT: HAMLET B | $116.39M | Skr5.92 | -12.94% |
| 4basebio PLCAIM: 4BB | $115.78M | £4.75 | -13.64% |
| Coya Therapeutics, Inc.NasdaqCM: COYA | $114.24M | $4.86 | -0.21% |
| enGene Therapeutics Inc.NasdaqCM: ENGN | $113.88M | $1.92 | +12.94% |
| Maxigen Biotech Inc.TWSE: 1783 | $113.78M | NT$40.40 | +0.25% |
| Kintor Pharmaceutical LimitedSEHK: 9939 | $113.69M | HK$1.81 | -2.17% |
| Devyser Diagnostics AB (publ)OM: DVYSR | $112.60M | Skr60.00 | -5.36% |
| Y-Biologics, Inc.KOSDAQ: A338840 | $111.21M | ₩10,230.00 | +2.51% |
| OBI Pharma, Inc.TPEX: 4174 | $111.15M | NT$26.90 | +2.09% |
| Pharma Foods International Co., Ltd.TSE: 2929 | $111.08M | ¥608.00 | -0.65% |
| ArcticZymes Technologies ASAOB: AZT | $110.80M | Nkr20.30 | -2.40% |
| Anterogen.Co.,Ltd.KOSDAQ: A065660 | $109.31M | ₩15,140.00 | -5.26% |
| Helix BioPharma Corp.TSX: HBP | $109.28M | CA$1.86 | -5.58% |
| Genexine, Inc.KOSDAQ: A095700 | $109.11M | ₩3,325.00 | +26.91% |
| Oncolytics Biotech Inc.NasdaqCM: ONCY | $109.10M | $0.86 | +0.02% |
| BioGend Therapeutics Co., Ltd.TPEX: 6733 | $108.62M | NT$25.75 | +1.98% |
| Cutia TherapeuticsSEHK: 2487 | $103.26M | HK$2.23 | -11.86% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $103.14M | $9.76 | -0.20% |
| Helixmith Co., LtdKOSDAQ: A084990 | $100.34M | ₩3,020.00 | -7.36% |
| Tenax Therapeutics, Inc.NasdaqCM: TENX | $100.24M | $2.21 | +26.00% |
| Adicet Bio, Inc.NasdaqCM: ACET | $98.92M | $9.52 | +3.59% |
| BioPorto A/SCPSE: BIOPOR | $98.60M | Dkr1.27 | -0.39% |
| AnGes, Inc.TSE: 4563 | $97.84M | ¥39.00 | -22.00% |
| Senhwa Biosciences, Inc.TPEX: 6492 | $97.69M | NT$34.80 | -10.31% |
| Great Novel Therapeutics Biotech & MedicalsTPEX: 7427 | $97.65M | NT$73.00 | +1.53% |
| Shine-On BioMedical Co.,Ltd.TPEX: 6926 | $97.37M | NT$62.80 | -0.79% |
| Kalaris Therapeutics, Inc.NasdaqGM: KLRS | $97.12M | $4.10 | +0.49% |
| Prestige Biologics Co., Ltd.KOSDAQ: A334970 | $97.06M | ₩1,730.00 | -13.24% |
| CanBas Co., Ltd.TSE: 4575 | $96.42M | ¥802.00 | +1.39% |
| Pelthos Therapeutics Inc.NYSEAM: PTHS | $95.58M | $25.00 | -9.09% |
| Bonraybio Co., Ltd.TWSE: 6955 | $95.34M | NT$123.00 | +0.82% |
| ISU Abxis Co., Ltd.KOSDAQ: A086890 | $95.33M | ₩3,240.00 | -5.54% |
| JW (Cayman) Therapeutics Co. LtdSEHK: 2126 | $94.65M | HK$1.83 | +2.23% |
| Atara Biotherapeutics, Inc.NasdaqGS: ATRA | $94.15M | $9.29 | -0.96% |
| Aldeyra Therapeutics, Inc.NasdaqCM: ALDX | $94.11M | $1.55 | -0.64% |
| GC Genome CorporationKOSDAQ: A340450 | $94.03M | ₩5,620.00 | +2.74% |
| Fortress Biotech, Inc.NasdaqCM: FBIO | $93.72M | $2.80 | -0.36% |
| Brii Biosciences LimitedSEHK: 2137 | $93.45M | HK$1.02 | +3.05% |
| Pet Pharm Biotech Co., Ltd.TPEX: 7762 | $92.96M | NT$51.20 | +2.50% |
| ReproCELL IncorporatedTSE: 4978 | $92.43M | ¥150.00 | +1.35% |
| HST Global, Inc.OTCPK: HSTC | $91.93M | $0.65 | — |
| OSE Immunotherapeutics SAENXTPA: OSE | $91.54M | €3.22 | -3.42% |
| ImmuCell CorporationNasdaqCM: ICCC | $91.37M | $10.09 | +0.30% |
| Adocia SAENXTPA: ADOC | $90.73M | €4.01 | +0.75% |
| Rallybio CorporationNasdaqCM: RLYB | $90.23M | $17.11 | +0.71% |
| TiumBio Co., Ltd.KOSDAQ: A321550 | $89.95M | ₩4,150.00 | -14.96% |
| Acrivon Therapeutics, Inc.NasdaqGM: ACRV | $89.13M | $2.16 | +3.61% |
| 3D Global Biotech Inc.TPEX: 6808 | $89.02M | NT$37.00 | -3.01% |
| Wuhan YZY Biopharma Co., Ltd.SEHK: 2496 | $88.93M | HK$3.60 | -1.37% |
| BIOTON S.A.WSE: BIO | $87.66M | zł3.80 | +0.80% |
| Gain Therapeutics, Inc.NasdaqGM: GANX | $87.51M | $1.86 | -7.23% |
| Revium Rx.OTCPK: RVRC | $86.84M | $1.43 | — |
| BRIM Biotechnology, Inc.TWSE: 6885 | $86.47M | NT$20.70 | +1.97% |
| Gossamer Bio, Inc.NasdaqGS: GOSS | $85.01M | $0.17 | -1.73% |
| Dogwood Therapeutics, Inc.NasdaqCM: DWTX | $84.64M | $2.33 | -6.43% |
| Citius Oncology, Inc.NasdaqCM: CTOR | $84.59M | $0.83 | -8.77% |
| MAIA Biotechnology, Inc.NYSEAM: MAIA | $84.55M | $1.39 | 0.00% |
| Energenesis Biomedical CO.,LTD.TWSE: 6657 | $84.48M | NT$30.60 | -0.16% |
| Sera Prognostics, Inc.NasdaqGM: SERA | $84.42M | $2.09 | -2.34% |
| Novogenia AGMUN: 7V0 | $83.08M | €6.00 | +0.84% |
| OKYO Pharma LimitedNasdaqCM: OKYO | $80.82M | $1.55 | +0.65% |
| ABIONYX Pharma SAENXTPA: ABNX | $80.51M | €1.95 | -2.30% |
| ViGenCell Inc.KOSDAQ: A308080 | $79.87M | ₩5,400.00 | -10.60% |
| GlycoNex IncorporationTPEX: 4168 | $79.86M | NT$22.60 | -0.88% |
| Cardiff Oncology, Inc.NasdaqCM: CRDF | $79.35M | $0.99 | -2.73% |
| Elicio Therapeutics, Inc.NasdaqCM: ELTX | $78.32M | $3.00 | +0.67% |
| Alterity Therapeutics LimitedASX: ATH | $76.40M | AU$0.49 | -10.09% |
| Forum Markets, IncorporatedNasdaqCM: FRMM | $76.03M | $5.76 | -2.12% |
| Allied Biotech CorporationTPEX: 1780 | $75.86M | NT$25.10 | +5.68% |
| Annovis Bio, Inc.NYSE: ANVS | $75.84M | $1.81 | +1.69% |
| Hofseth BioCare ASAOB: HBC | $75.51M | Nkr1.35 | +0.37% |
| Paradigm Biopharmaceuticals LimitedASX: PAR | $74.51M | AU$0.18 | -2.78% |
| Cell Biotech Co., Ltd.KOSDAQ: A049960 | $73.88M | ₩14,960.00 | -3.73% |
| OS Therapies IncorporatedNYSEAM: OSTX | $72.15M | $1.68 | +3.70% |